Combined systemic administration of morphine and magnesium sulfate attenuates pain-related behavior in mononeuropathic rats
dc.authorid | Ulugol, Ahmet/0000-0003-4643-1124 | |
dc.authorid | Karadag, Cetin Hakan/0000-0002-4763-986X | |
dc.authorwosid | Ulugol, Ahmet/V-9665-2019 | |
dc.authorwosid | Karadag, Cetin Hakan/H-4899-2013 | |
dc.contributor.author | Ulugol, A | |
dc.contributor.author | Aslantas, A | |
dc.contributor.author | Ipci, Y | |
dc.contributor.author | Tuncer, A | |
dc.contributor.author | Karadag, CH | |
dc.contributor.author | Dokmeci, I | |
dc.date.accessioned | 2024-06-12T11:09:11Z | |
dc.date.available | 2024-06-12T11:09:11Z | |
dc.date.issued | 2002 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | The response to opioids is reduced in neuropathic pain states. We examined the effect of the combination of morphine (0.1 mg/kg) and magnesium sulfate (125 mg/kg) on behavioral signs of neuropathic pain in spinal nerve ligated rats. Administered alone, neither drug produced any effect, but the combination exerted a significant anti-allodynic effect, which was partially reversed by naloxone. These results suggest that combining low doses of magnesium sulfate with opiates might be an alternative in treating neuropathic pain, with reduced risk of side effects. (C) 2002 Elsevier Science B.V. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/S0006-8993(02)02618-5 | |
dc.identifier.endpage | 104 | en_US |
dc.identifier.issn | 0006-8993 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 12088843 | en_US |
dc.identifier.scopus | 2-s2.0-0037024943 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 101 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0006-8993(02)02618-5 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22698 | |
dc.identifier.volume | 943 | en_US |
dc.identifier.wos | WOS:000177021000012 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Brain Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neuropathic Pain | en_US |
dc.subject | Allodynia | en_US |
dc.subject | Morphine | en_US |
dc.subject | Magnesium | en_US |
dc.subject | Nmda-Receptor Antagonists | en_US |
dc.subject | Neuropathic Pain | en_US |
dc.subject | Peripheral Neuropathy | en_US |
dc.subject | Spinal-Cord | en_US |
dc.subject | Opioids | en_US |
dc.subject | Neurons | en_US |
dc.subject | Antinociception | en_US |
dc.subject | Potentiation | en_US |
dc.subject | Responses | en_US |
dc.subject | Models | en_US |
dc.title | Combined systemic administration of morphine and magnesium sulfate attenuates pain-related behavior in mononeuropathic rats | en_US |
dc.type | Article | en_US |